Raymond James & Associates Invests $3.01 Million in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

Raymond James & Associates acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXHGet Rating) in the 3rd quarter, HoldingsChannel reports. The fund acquired 125,025 shares of the company’s stock, valued at approximately $3,006,000. Raymond James & Associates owned approximately 0.08% of First Trust Nasdaq Pharmaceuticals ETF at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. D.A. Davidson & CO. bought a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter worth $6,332,000. AE Wealth Management LLC bought a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter worth $4,213,000. Truist Financial Corp boosted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 172.6% during the 2nd quarter. Truist Financial Corp now owns 54,867 shares of the company’s stock worth $1,450,000 after buying an additional 34,737 shares during the period. WMG Financial Advisors LLC boosted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 30.5% during the 3rd quarter. WMG Financial Advisors LLC now owns 41,967 shares of the company’s stock worth $1,006,000 after buying an additional 9,800 shares during the period. Finally, Integrated Advisors Network LLC boosted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 5.8% during the 2nd quarter. Integrated Advisors Network LLC now owns 38,184 shares of the company’s stock worth $1,009,000 after buying an additional 2,101 shares during the period.

First Trust Nasdaq Pharmaceuticals ETF Stock Up 0.1 %

NASDAQ FTXH opened at $27.65 on Friday. The company has a fifty day simple moving average of $27.62 and a 200 day simple moving average of $26.39. First Trust Nasdaq Pharmaceuticals ETF has a 1 year low of $23.87 and a 1 year high of $28.45.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 30th. Shareholders of record on Tuesday, December 27th were issued a $0.125 dividend. The ex-dividend date was Friday, December 23rd. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.09. This represents a $0.50 dividend on an annualized basis and a yield of 1.81%.

Further Reading

Want to see what other hedge funds are holding FTXH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXHGet Rating).

Institutional Ownership by Quarter for First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

Receive News & Ratings for First Trust Nasdaq Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust Nasdaq Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.